Missouri Bill Would Add Psychedelics to ‘Right to Try’ Law
Fri / Feb 26th
A Missouri lawmaker has proposed expanding the state’s Right to Try law to include psychedelic substances such as psilocybin, MDMA, LSD, mescaline, ibogaine, and DMT.
Psychedelics like psilocybin have been decriminalized in cities like Denver, causing the news to look more deeply at the possible benefits of the plants. Read news and stories about psychedelics in this section:
Fri / Feb 26th
A Missouri lawmaker has proposed expanding the state’s Right to Try law to include psychedelic substances such as psilocybin, MDMA, LSD, mescaline, ibogaine, and DMT.
Thu / Feb 11th
As an entrepreneur, Michael “Zappy” Zapolin is known as a pioneer in the domain name industry. As a filmmaker, he has emerged as a powerful advocate for the legalization and normalization of psychedelics.
Mon / Feb 8th
New Jersey Gov. Phil Murphy has signed legislation reducing the penalties for the possession of psilocybin mushrooms from a third-degree crime to a disorderly person offense.
Mon / Dec 14th
The UK has approved trials to assess the safety — and eventually efficacy — of DMT as a potential treatment for depression.
Tue / Dec 8th
Lawmakers in New Jersey’s Assembly Judiciary Committee have advanced a bill that would lower possession penalties for psilocybin mushrooms from a potential 5-year prison sentence to a maximum $1,000 fine and six months in jail.
Thu / Nov 5th
A recent study found that psilocybin therapy offered “more than four times greater” relief than traditional antidepressant medications.
Wed / Nov 4th
With the landmark passage of Measures 109 and 110, Oregon voters have opted to decriminalize drugs and legalize medicinal psilocybin.
Wed / Nov 4th
Voters in Washington, D.C. have overwhelmingly approved Initiative 81 to decriminalize psychedelic plants.
Tue / Nov 3rd
Across the U.S. today, voters from Montana to New Jersey will consider a series of ballot initiatives that could represent yet another dramatic shift for the country away from our archaic cannabis and drug policies.
Wed / Sep 23rd
The Ann Arbor, Michigan City Council has unanimously passed a resolution to decriminalize naturally occurring psychedelics, including mushrooms and ayahuasca.
Thu / Jul 9th
Oregon’s initiative to legalize the medicinal use of psilocybin has officially qualified for the November ballot.
Thu / Jun 25th
The U.S. Defense Advanced Research Projects Agency is funding a medical health study into the therapeutic use of psychedelics such as ketamine and psilocybin.
Tue / May 12th
The latest documentary from streaming platform Netflix features celebrity interviews and re-enactments of psychedelic experiences alongside real information about psychotropic medicines. Have a Good Trip: Adventures in Psychedelics is a wonderfully built look at your brain on drugs — but in a good way.
Mon / May 11th
Separate campaigns to legalize psilocybin therapy and to decriminalize all illegal drugs have teamed up in Oregon to gather signatures.
Mon / May 4th
The Dr. Bronners soap company announced it has contributed $1 million to the psilocybin therapy legalization campaign in Oregon.
Mon / Apr 6th
In celebration of the 4/20 holiday this month, we are using the whole month of April to focus on courageous cannabis and drug policy pioneers. Today, on what would have been his 89th birthday, we celebrate Baba Ram Dass, who helped legitimize the psychedelic revolution of the 1960s and awaken the public to the immorality of prohibition.
Thu / Apr 2nd
New York City-based Mind Medicine announced it had partnered with the world-leading psychedelics pharmacology and clinical research laboratory at University Hospital Basel in Switzerland.
Thu / Jan 23rd
A Vermont state lawmaker has pitched the decriminalization of three psychedelic substances — psilocybin, ayahuasca, and peyote — as well as kratom.
Wed / Oct 2nd
Scientists have created a bacteria solution that exudes industrial quantities of psilocybin, the psychedelic compound in “magic mushrooms” that is being studied as a potentially groundbreaking treatment for depression and other mental health afflictions.
Tue / Sep 10th
Researchers at Johns Hopkins University announced last week the formation of what is likely the world’s largest research facility dedicated to psilocybin and psychedelic medicinal research.
Thu / May 9th
Denver voters have passed a city initiative decriminalizing the adult possession and use of psilocybin (a.k.a. psychedelic) mushrooms. It is the first successful initiative of its kind in the U.S.
Wed / Nov 28th
The Oregon Attorney General has approved the wording of a medical psilocybin ballot initiative, which is the final step before… Read More
Wed / Oct 31st
Speaker of the House Paul Ryan (R-Wisconsin) gave a surprise endorsement on Tuesday to industrial hemp and cannabidiol (CBD), the… Read More
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.